• Health & Medicine

Discovery could guide immunotherapy for lung cancer

Scientists have discovered a new type of immune cell that could predict which lung cancer patients will benefit most from immunotherapy treatment. Scientists have discovered a new type of immune cell that could predict which lung cancer patients will benefit most from immunotherapy treatment.

19 June 2017

• Health & Medicine

Blood test could help personalise treatment for advanced prostate cancer

Scientists have developed a blood test that could help doctors select the best treatment for men with aggressive prostate cancer. Scientists have developed a blood test that could help doctors select the best treatment for men with aggressive prostate cancer.

19 June 2017

• Science & Technology
• Health & Medicine

News digest - smoking rates falling, aspirin risks, breast cancer drug U-turn and… ‘tanning drugs’?

Smoking rates are falling, aspirin has risks as well as benefits and… what's behind the talk of ‘tanning drugs’? Here's our weekly news report. Smoking rates are falling, aspirin has risks as well as benefits and… what's behind the talk of ‘tanning drugs’? Here's our weekly news report.

17 June 2017

• Science & Technology

Certain genetic faults could help predict success of immunotherapy

A certain group of genetic faults could be used to help predict if immunotherapy will work in cancer patients, according to a new US study. A certain group of genetic faults could be used to help predict if immunotherapy will work in cancer patients, according to a new US study.

9 June 2017

• Health & Medicine

Combining immunotherapies could benefit some aggressive breast cancers

Using two immunotherapy drugs together could help treat some patients with an aggressive form of breast cancer, according to an Australian study. Using two immunotherapy drugs together could help treat some patients with an aggressive form of breast cancer, according to an Australian study.

8 June 2017

• Health & Medicine
• Science & Technology

‘Once in a career feeling’ as trial shows offering prostate cancer drug earlier improves survival

We take a look at results from the STAMPEDE clinical trial, which is researching how to improve treatment for men with prostate cancer. We take a look at results from the STAMPEDE clinical trial, which is researching how to improve treatment for men with prostate cancer.

6 June 2017

• Health & Medicine

New chemotherapy approach offers breast cancer patients a better quality of life

The chemotherapy drug capecitabine gives patients a better quality of life and is as effective at preventing breast cancer from returning as the alternative CMF The chemotherapy drug capecitabine gives patients a better quality of life and is as effective at preventing breast cancer from returning as the alternative CMF

6 June 2017

• Health & Medicine

Two clinical trials show promise with different targeted drugs for lung cancer

Two drugs targeting different gene faults in lung cancer have shown potential to be better than those already available. Two drugs targeting different gene faults in lung cancer have shown potential to be better than those already available.

6 June 2017

• Health & Medicine

Ovarian cancer drug reduces chance certain advanced breast cancers will get worse

A drug that’s already approved to treat certain ovarian cancers holds some advanced breast cancers at bay longer than standard chemotherapy. A drug that’s already approved to treat certain ovarian cancers holds some advanced breast cancers at bay longer than standard chemotherapy.

4 June 2017

• Health & Medicine

Giving prostate cancer drug earlier extends lives of men whose disease has spread

Offering abiraterone (Zytiga) up-front with standard hormone treatment extends survival in men whose prostate cancer has spread. Offering abiraterone (Zytiga) up-front with standard hormone treatment extends survival in men whose prostate cancer has spread.

3 June 2017

• Health & Medicine

Adding abiraterone to standard treatment improves prostate cancer survival by 40 per cent

Adding abiraterone to hormone therapy at the start of treatment for prostate cancer improves survival by 37 per cent. Adding abiraterone to hormone therapy at the start of treatment for prostate cancer improves survival by 37 per cent.

3 June 2017